Cholesterol Modulation of the Expression of Mitochondrial Aconitase in Human Prostatic Carcinoma Cells

Tsui-Hsia Feng；Ke-Hung Tsui；Horng-Heng Juang

prostate ； cholesterol ； citrate ； mevastatin ； PC-3 ； HepG2 ； ATP ； sterol response element

The Chinese Journal of Physiology

48卷2期（2005 / 06 / 01）

93 - 100

英文

Mitochondrial aconitase (mACON) is the key enzyme for the citrate oxidation in the mitochondrial Krebs cycle. Cholesterol treatment (10 μg/ml of cholesterol and 1 μg/ml of 25-hydroxycholesterol) for 24 h stimulates mACON enzymatic activity in human prostatic carcinoma cells (PC-3) and hepatoma cells (HepG2). Mevastatin, a cholesterol synthesis antagonist, blocked the effect of cholesterol treatment on mACON. The cholesterol treatment stimulated mACON enzymatic activity, which enhanced the citrate utility but decreased intracellular ATP levels in PC-3 cells. The immunoblotting and transient gene expression assays demonstrated that cholesterol treatment enhances the gene expression of mACON. Mutation of the putative sterol response element (SRE) from GACGCCCCACT to GACGCCCATAT abolished the stimulating effects of cholesterol on the promoter activity of mACON gene. The results suggest that cholesterol treatment induces the mACON gene expression through the SRE signal transduction pathway. Our study demonstrated the deregulation of cholesterol on the citrate metabolism.

1. Baggetto, L.G.,Clottes, E.,Vial, C.(1992).Low mitochondrial proton leak due to high membrane cholesterol content and cytosolic creatine kinase as two features of the deviant bioenergetics of Ehrlich and AS30-D tumor cells.Cancer Res.,52,4935-4941.
2. Brown, M.X.,Goldstein, J.L.(1997).The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor.Cell,89,331-340.
3. Coleman, P.S.(1986).Membrane cholesterol and tumor bioenergetics.Ann. NY. Acad. Sci.,488,451-467.
4. Coleman, P.S.,Lavietes, B.B.(1981).Membrane cholesterol, tumorigenesis, and the biochemical phenotype of neoplasia.CRC Crit. Rev. Biochem,11,341-393.
5. Costello, L.C.,Franklin, R.B.(1991).Concepts of citrate production and secretion by prostate: 1 Metabolic relationships.Prostate,18,25-46.
6. Costello, L.C.,Franklin, R.B.(1994).The bioenergetic theory of prostate malignancy.Prostate,25,162-166.
7. Costello, L.C.,Franklin, R.B.(2000).The intermediary metabolism of the prostate: A key to understanding the pathogenesis and progression of prostate malignancy.Oncology,59,269-282.
8. Dietzen, D.J.,Davis, E.J.(1994).Excess membrane cholesterol is not responsible for metabolic and bioenergetic changes in AS-30D hepatoma mitochondria.Arch. Biochem. Biophy,309,341-347.
9. Emptage, M.H.,Kent, T.A.,Kennedy, M.C.,Beinert, H.,Munck, E.(1983).Mossbauer and EPR studies of activated aconitases: development of a localized valence state at a subsite of the [4Fe-4S] cluster on binding of citrate.Proc. Natl. Acad. Sci. USA,80,4674-4678.
10. Ericsson, J.,Jackson, S.M.,Lee, B.C.,Edwards, P.A.(1996).Sterol regulatory element binding protein binds to a cis element in the promoter of the farnesyl diphosphate synthase gene.Proc. Natl. Acad. Sci. USA,93,945-950.
11. Gauthier, B.,Robb, M.,Gaudet, F.,Sinsburg, G.S.,McPherson, R.(1999).Characterization of a cholesterol response element (CRE) in the promoter of the cholesteroyl ester transfer protein gene: functional role of the transcription factor SREBP-1a, -2, and YY1.J. Lipid Res.,40,1284-1293.
12. Heemers, H.,Mares, B.,Foufelle, F.,Heyns, W.,Verhoeven, G.,Swinnen, J.V.(2001).Androgens stimulate lipogenic gene expression in prostate cancer cells by activation of the sterol regulatory elementbinding protein cleavage activating protein/sterol regulatory element- binding protein pathway.Mol. Endocrinol,15,1817-1828.
13. Janson, L.,Bark, C.,Pettersson, U.(1987).Identification of proteins interacting with the enhancer of human U2 small nuclear RNA genes.Nucleic Acids Res.,15,4997-5016.
14. Juang, H.H.(2004).Cyclic adenosine 3`, 5`-monosphosphate mediate prolactin regulation of mitochondrial aconitase in human prostate carcinoma cells.Mol. Cell. Endocrinol,219,141-149.
15. Juang, H.H.(2004).Modulation of mitochondrial aconitase on the bioenergy of human prostate carcinoma cells.Mol. Genet. Metab,81,244-252.
16. Juang, H.H.(2004).Nitroprusside stimulates mitochondrial aconitase gene expression through the cyclic adenosine 3`, 5`-monosphosphate signal transduction pathway in human prostate carcinoma cells.Prostate,61,92-102.
17. Juang, H.H.,Hsieh, M-L.,Tsui, K-H.(2004).Testosterone modulates mitochondrial aconitase in the full-length human androgen receptor- transfected PC-3 prostatic carcinoma cells.J. Mol. Endocrinol,33,121-132.
18. Lane, M.D.,Watkins, P.A.,Meredith, M.J.(1979).Hormonal regulation of acetyl-CoA carboxylase activity in the liver cells.CRC Crit. Rev. Biochem,7,121-141.
19. Lopez, J.M.,Bennett, M.K.,Sanchez, H.B.,Rosenfeld, J.M.,Osborne, T. F.(1996).Sterol regulation of acetyl coenzyme A carboxylase: A mechanism for coordinate control of cellular lipid.Proc. Natl. Acad. Sci. USA,93,1049-1053.
20. Ness, G.C.,Chambers, C.M.(2000).Feedback and hormonal regulation of hepatic 3-hydroxy -3-methylglutaryl Coenzyme A reductase: The concept of cholesterol buffering capacity.Proc. Soc. Exp. Biol. Med.,224,8-19.
21. Osborne, T.F.,Gil, G.,Brown, M.S.,Kowal, R.C.,Goldstein, J.L.(1987).Identification of promoter elements required for in vitro transcription of hamster 3-hydroxy-3-methylglutaryl coenzyme A reductase gene.Proc. Natl. Acad. Sci. USA,84,3614-3618.
22. Osborne, T.F.,Gil, G.,Goldstein, J.L.,Brown, M.S.(1988).Operator constitutive mutation of 3-hydroxy-3methylglutaryl coenzyme A reductase promoter abolishes protein binding to sterol regulatory element.J. Biol. Chem,263,3380-3387.
23. Papadopoulo, V.(2003).Peripheral benzodiazepine receptor: structure and function in health and disease.Ann. Phar. Fr.,61,30-50.
24. Parlo, R.A.,Coleman, P.S.(1984).Enhanced rate of citrate export from cholesterol-rich hepatoma mitochondria. The truncated Krebs cycle and other metabolic ramification of mitochondrial membrane cholesterol.J. Biol. Chem,259,9997-10003.
25. Sabine, J.R.(1976).Metabolic controls in precancerous liver-VII. Time course of loss of dietary feedback control of cholesterol synthesis during carcinogen treatment.Eur. J. Cancer,12,299-303.
26. Sack, S.,Gorospe, M.,Fawcett, T.W.,Hudgins, W.R.,Holbrook, N.J.(1999).Activation of the cholesterol pathway and Ras maturation in response to stress.Oncogenen,18,6021-6028.
27. Spitsen, G.M.,Dueland, S.,Krisans, S.K.,Slattery, C.J.,Miyake, J. H.,Davis, R.A.(2000).In nonhepatic cells, cholesterol 7α-hydroxylase induces the expression of genes regulating cholesterol biosynthesis efflux, and homeostasis.J. Lipid Res.,41,1347-1355.
28. Swinnen, J.V.,Aln, P.,Heyns, W.,Verhoeven, G.(1998).Identification of Diazepam-binding inhibitor/Acyl-CoA-binding protein as a sterol regulatory element-binding protein-responsive gene.J. Biol. Chem,273,19938-19944.
29. Swinnen, J.V.,Ulrix, W.,Heyns, W.,Verhoeven, G.(1997).Coordinate regulation of lipogenic gene expression by androgens: Evidence for a cascade mechanism involving sterol regulatory element binding protein.Proc. Natl. Acad. Sci. USA,94,12975-12980.
30. Swinnen, J.V.,Van Veldhoven, P.P.,Esquenet, M.,Heyns, W.,Verhoeven, G.(1996).Androgens markedly stimulate the accumulation of neutral lipids in the human prostatic adenocarcinoma cell line LNCaP.Endocrinology,137,4468-4474.
31. Swinnen, J.V.,Verhoeven, G.(1998).Androgen and the control of lipid metabolism in human prostate cancer cells.J. Steroid Biochem, Mol. Biol,65,191-198.
32. Tsui, K-H.,Chang, P-L.,Lin, H-T.,Juang, H-H.(2004).Down-regulation of the prostate specific antigen promoter by p53 in human prostate cancer cells.J. Urol.,172,2305-2309.
33. Yokoyama, C.,Wang, X.,Briggs, M.,Admon, A.,Wu, J.,Hua, X.,Goldstein, J.L.,Brown, MS.(1993).SREBP-1, a basic-helix-loophelix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene.Cell,75,187-197.